CARSGEN-B (02171) Announces Monthly Equity Movements for February 2026

Bulletin Express03-05

CARsgen Therapeutics Holdings Limited reported that its authorized share capital remained at 200.00 billion ordinary shares with a par value of USD 0.00000025 each, totaling USD 50,000. As of the close of February 2026, there were 570.31 million issued shares (excluding treasury shares) alongside 7.82 million treasury shares, resulting in a total of 578.13 million issued shares—unchanged from the prior month.

The company confirmed that its public float requirement of 25% remained fulfilled. Under the Post-IPO Share Option Scheme, 14.60 million share options were outstanding at the beginning of February. After 40,000 options lapsed, 14.56 million remained, and 27.66 million shares in total could be issued under the scheme. Furthermore, 2.32 million shares remained issuable under the 2019 Equity Incentive Plan.

No new shares were issued during the month, and no shares were transferred out of treasury. A total of 0.46 million shares had been repurchased previously but were not yet canceled as of the end of February 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189877268?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-05 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189877268","market":"hk","top_or_hot":-1,"title":"CARSGEN-B (02171) Announces Monthly Equity Movements for February 2026","media":"Bulletin Express","content":"<p>CARsgen Therapeutics Holdings Limited reported that its authorized share capital remained at 200.00 billion ordinary shares with a par value of USD 0.00000025 each, totaling USD 50,000. As of the close of February 2026, there were 570.31 million issued shares (excluding treasury shares) alongside 7.82 million treasury shares, resulting in a total of 578.13 million issued shares—unchanged from the prior month.</p>\n<p>The company confirmed that its public float requirement of 25% remained fulfilled. Under the Post-IPO Share Option Scheme, 14.60 million share options were outstanding at the beginning of February. After 40,000 options lapsed, 14.56 million remained, and 27.66 million shares in total could be issued under the scheme. Furthermore, 2.32 million shares remained issuable under the 2019 Equity Incentive Plan.</p>\n<p>No new shares were issued during the month, and no shares were transferred out of treasury. A total of 0.46 million shares had been repurchased previously but were not yet canceled as of the end of February 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CARSGEN-B (02171) Announces Monthly Equity Movements for February 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCARSGEN-B (02171) Announces Monthly Equity Movements for February 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-05 18:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CARsgen Therapeutics Holdings Limited reported that its authorized share capital remained at 200.00 billion ordinary shares with a par value of USD 0.00000025 each, totaling USD 50,000. As of the close of February 2026, there were 570.31 million issued shares (excluding treasury shares) alongside 7.82 million treasury shares, resulting in a total of 578.13 million issued shares—unchanged from the prior month.</p>\n<p>The company confirmed that its public float requirement of 25% remained fulfilled. Under the Post-IPO Share Option Scheme, 14.60 million share options were outstanding at the beginning of February. After 40,000 options lapsed, 14.56 million remained, and 27.66 million shares in total could be issued under the scheme. Furthermore, 2.32 million shares remained issuable under the 2019 Equity Incentive Plan.</p>\n<p>No new shares were issued during the month, and no shares were transferred out of treasury. A total of 0.46 million shares had been repurchased previously but were not yet canceled as of the end of February 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02171","symbol_name":"科济药业-B","start_time":0,"source_url":"","article_id":"1189877268","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189877268","pubTimestamp":1772707406,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CARsgen Therapeutics Holdings Limited reported that its authorized share capital remained at 200.00 billion ordinary shares with a par value of USD 0.00000025 each, totaling USD 50,000. As of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02171":"科济药业-B"},"translate_title":"科济康-B(02171)公布2026年2月权益变动月","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02171":1},"content_text":"CARsgen Therapeutics Holdings Limited reported that its authorized share capital remained at 200.00 billion ordinary shares with a par value of USD 0.00000025 each, totaling USD 50,000. As of the close of February 2026, there were 570.31 million issued shares (excluding treasury shares) alongside 7.82 million treasury shares, resulting in a total of 578.13 million issued shares—unchanged from the prior month.\nThe company confirmed that its public float requirement of 25% remained fulfilled. Under the Post-IPO Share Option Scheme, 14.60 million share options were outstanding at the beginning of February. After 40,000 options lapsed, 14.56 million remained, and 27.66 million shares in total could be issued under the scheme. Furthermore, 2.32 million shares remained issuable under the 2019 Equity Incentive Plan.\nNo new shares were issued during the month, and no shares were transferred out of treasury. A total of 0.46 million shares had been repurchased previously but were not yet canceled as of the end of February 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189877268","isCrawlerRequest":true}